Debt-to-equity of BIOFORCE NANOSCIENCES HOLDINGS, INC. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
BIOFORCE NANOSCIENCES HOLDINGS, INC. quarterly Debt-to-equity in % history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • BIOFORCE NANOSCIENCES HOLDINGS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was -100%, a 0.43% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

BIOFORCE NANOSCIENCES HOLDINGS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -100% 0% -0.43% 30 Sep 2025
Q2 2025 -100% 0% -0.3% 30 Jun 2025
Q1 2025 -100% 0% -0.21% 31 Mar 2025
Q4 2024 -100% 0% 0% 31 Dec 2024
Q3 2024 -100% 0% 0% 30 Sep 2024
Q2 2024 -100% 0% +0.02% 30 Jun 2024
Q1 2024 -100% 0% +0.18% 31 Mar 2024
Q4 2023 -100% 0% +0.43% 31 Dec 2023
Q3 2023 -100% +1% +0.72% 30 Sep 2023
Q2 2023 -100% +2% +1.5% 30 Jun 2023
Q1 2023 -100% +2% +2.1% 31 Mar 2023
Q4 2022 -100% +3% +3% 31 Dec 2022
Q3 2022 -101% +5% +4.6% 30 Sep 2022
Q2 2022 -102% +6% +6% 30 Jun 2022
Q1 2022 -102% +10% +9.1% 31 Mar 2022
Q4 2021 -104% +21% +17% 31 Dec 2021
Q3 2021 -106% +58% +36% 30 Sep 2021
Q2 2021 -108% +1243% +92% 30 Jun 2021
Q1 2021 -113% -158% -350% 31 Mar 2021
Q4 2020 -125% -141% -866% 31 Dec 2020
Q3 2020 -164% -178% -1267% 30 Sep 2020
Q2 2020 -1351% -1368% -7868% 30 Jun 2020
Q1 2020 45% 31 Mar 2020
Q4 2019 16% 31 Dec 2019
Q3 2019 14% 30 Sep 2019
Q2 2019 17% 30 Jun 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.